We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NBTB:NASDAQNBT Bancorp Inc. Analysis

Data as of 2026-04-19 - not real-time

$45.65

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

NBT Bancorp is trading at $45.65, comfortably above its 20‑day (≈$43.58) and 200‑day (≈$42.72) moving averages, indicating a sustained bullish trend. The RSI sits at 64.9, well below the overbought threshold, while the MACD histogram remains positive, reinforcing momentum. Volume has been tapering, suggesting a potential pause as the stock nears its near‑term resistance around $46.43. Fundamentally, the company posts a forward PE of roughly 10 versus an industry average of 17.7, and its dividend yield of 3.17% is backed by a 42% payout ratio, pointing to dividend sustainability. Revenue growth of 24% and an operating margin above 40% highlight strong earnings power, while a modest debt‑to‑equity profile keeps balance‑sheet risk in check. The market sentiment is extremely bullish (Fear‑Greed Index 90), yet the recent director share sale adds a minor cautionary note. Overall, the stock appears undervalued relative to its DCF fair value and offers attractive yield and growth prospects, but investors should watch for a potential short‑term pull‑back near resistance.
In the medium to long term, the combination of a low relative valuation, solid profitability, and a sustainable dividend supports a positive outlook, though the sector’s inherent regulatory and regional‑bank risks remain a backdrop to consider.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price approaching near‑term resistance
  • Decreasing volume indicating possible short‑term pause
  • Bullish technical indicators still intact

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to peers (PE ~13.7 vs industry ~17.7)
  • Strong revenue growth and operating margin
  • Sustainable dividend yield of 3.17%

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair value far above current price
  • Consistent profitability and low debt profile
  • Stable cash generation supporting dividend continuity

Key Metrics & Analysis

Financial Health

Revenue Growth24.00%
Profit Margin25.46%
P/E Ratio13.7
ROE9.89%
ROA1.14%
P/B Ratio1.3
Op. Cash Flow$235.2M
Industry P/E17.7

Technical Analysis

TrendBullish
RSI64.9
Support$40.38
Resistance$46.43
MA 20$43.58
MA 50$43.57
MA 200$42.72
MACDBullish
VolumeDecreasing
Fear & Greed Index90.21

Valuation

Fair Value$114.81
Target Price$48.83
Upside/Downside6.97%
GradeUndervalued
TypeBlend
Dividend Yield3.17%

Risk Assessment

Beta0.95
Volatility19.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.